Levodopa-induced Dyskinesias

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-04-02
Clinical Trial Update: Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID. [Phase 3]
Phase 3 trial of extended-release amantadine HCl for Parkinson's disease with levodopa-induced dyskinesias was terminated; results posted in…